About Interferon regulatory factor 4
Interferon regulatory factor 4 (IRF4) is a protein
from Homo sapiens identified by UniProt accession
Q15306, 451 residues long.
MolForge cross-references it against 0 known binders and
764 disease associations.
Target properties
| Protein name | Interferon regulatory factor 4 |
| UniProt accession | Q15306 |
| Gene | IRF4 |
| Organism | Homo sapiens |
| Length | 451 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (764)
Diseases linked to this target (Open Targets).
- multiple myeloma · score 0.56
- neurodegenerative disease · score 0.54
- chronic lymphocytic leukemia · score 0.53
- hair color · score 0.45
- diffuse large B-cell lymphoma · score 0.43
- lymphocyte count · score 0.42
- skin pigmentation · score 0.41
- hair colour measurement · score 0.40
- adult T-cell leukemia/lymphoma · score 0.39
- eosinophil count · score 0.39
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q15306-F1 | alphafold | PREDICTED | 71.58 | — |
Amino-acid sequence (451 residues)
MNLEGGGRGG EFGMSAVSCG NGKLRQWLID QIDSGKYPGL VWENEEKSIF RIPWKHAGKQ DYNREEDAAL FKAWALFKGK FREGIDKPDP PTWKTRLRCA LNKSNDFEEL VERSQLDISD PYKVYRIVPE GAKKGAKQLT LEDPQMSMSH PYTMTTPYPS LPAQQVHNYM MPPLDRSWRD YVPDQPHPEI PYQCPMTFGP RGHHWQGPAC ENGCQVTGTF YACAPPESQA PGVPTEPSIR SAEALAFSDC RLHICLYYRE ILVKELTTSS PEGCRISHGH TYDASNLDQV LFPYPEDNGQ RKNIEKLLSH LERGVVLWMA PDGLYAKRLC QSRIYWDGPL ALCNDRPNKL ERDQTCKLFD TQQFLSELQA FAHHGRSLPR FQVTLCFGEE FPDPQRQRKL ITAHVEPLLA RQLYYFAQQN SGHFLRGYDL PEHISNPEDY HRSIRHSSIQ E
Explore Interferon regulatory factor 4 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets